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Toward a Better Understanding of...

Employing Human Induced Pluripotent
Stem Cells (hiPSCs) to Model NF1-Associated
Low Grade Gliomas
Kelly Hartigan
Mentor: David Gutmann
Neurofibromatosis type 1 (NF1) is a clinically heterogeneous cancer predisposition
syndrome caused by a germline mutation in one of the two alleles of the NF1 gene. Low
grade gliomas (LGGs), particularly in the optic pathway, are common in patients with NF1
(15-20%). These tumors arise when the remaining allele is somatically inactivated in glial
progenitor cells. Nf1 genetically-engineered mouse (GEM) models have been employed
to study NF1-associated LGGs; however, there are still a limited number of therapeutic
targets available. This lack of clinical translation could reflect species-specific differences
between rodents and humans or the use of “knockout” mutations in the mouse models,
whereas patients with NF1 harbor a diverse number of germline NF1 gene mutations. To
study the importance of the germline mutation to LGG development and progression
in human cells, the Gutmann Laboratory has created a collection of human induced
pluripotent stem cells (hiPSCs) with NF1 patient mutations and hiPSC-derived cerebral
organoids. Using this resource, we have generated mixed cerebral organoids comprised
of hiPSCs homozygous for patient-specific NF1 mutations and hiPSCs heterozygous for
distinct NF1 mutations spanning the NF1 gene. Our preliminary results demonstrate
that these mixed organoid cultures exhibit histological characteristics of NF1-LGGs.
Future experiments employing this model will evaluate the differential effects of NF1
mutations on LGG formation and growth.
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